Table 1: Summary of laboratory findings over a 21-day period from 17 days prior to treatment with imatinib to 4 days post treatment.
| Laboratory parameter (Normal range) | Admission day -17 | Day -15 | Day -7 | Day +1 | Day +2 | Day +3 | Day +4 (death) |
|---|---|---|---|---|---|---|---|
| WBC (4500-11000/μL) | 11200 | 11300 | 20300 | 24600 | 17600 | 22200 | |
| Hb (Male: 14-18 g/dL) | 14.1 | 13.8 | 13.8 | 12.6 | 12.2 | 10.9 | |
| Platelet (150-350/μL) | 193 | 178 | 134 | 122 | 68 | 61 | |
| Na (135-147 mmol/L) | 145 | 146 | 137 | 154 | 148 | 156 | 144 |
| K (3.4-4.7 mmol/L) | 3.2 | 2.7 | 4.3 | 5.4 | 8.8 | 7.4 | 6.3 |
| BUN (7-20 mg/dL) | 13 | 13 | 11 | 62 | 84 | 78 | 41 |
| Creatinine (0.7-1.5 mg/dL) | 1.2 | 1.1 | 1.2 | 3.3 | 5.8 | 5.4 | 4.6 |
| Phosphate (2.1-4.7 mg/dL) | 3 | 3.5 | 4.2 | 11.8 | 9.2 | ||
| Free calcium (1.13-1.31 mmol/L) | 1.26 | 0.81 | 0.76 | 0.72 | 0.79 | ||
| LDH (131-250 U/L) | 304 | 358 | 480 | 9390 | 14800 | 37 | |
| Uric acid (Male: 2.5-7.2 mg/dL) | 10.4 | 10.1 | 19.2 | 27.3 | 15.3 | ||
| Ammonia (5-69 ug/dL) | 248 | 858 | |||||
| Albumin (3.7-5.3 g/dL) | 3.3 | 2.9 | 2.8 | ||||
| CK (27-168 U/L) | 75 | 84 | 35 | 77 | |||
| CRP (0-0.5 mg/dL) | 1 | 1 | |||||
| ALT (0-40 U/L) | 43 | 78 | 59 | 128 | 5250 | ||
| AST (5-45 U/L) | 74 | 211 | 13900 | ||||
| TB (0.2-1.6 mg/dL) | 3.5 | 3.7 | 4.6 | 15.4 | |||
| DB (0-0.3 mg/dL) | 1.4 | 1.6 | 2.4 | 6.5 | |||
| Alk-P (10-100 U/L) | 242 | 226 | 211 | 225 |
WBC: White Blood Cell; Hb: Hemoglobin; Na: Sodium; K: Potassium; BUN: Blood Urea Nitrogen; LDH: Lactate Dehydrogenase; CK: Creatine Kinase; CRP: C-Reactive Protein; ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; TB: Total Bilirubin; DB: Direct Bilirubin; Alk-P: Alkaline Phosphatase.